Thrive Capital Management (Pennsylvania)’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.37M Buy
32,859
+3,923
+14% +$443K 0.74% 65
2025
Q4
$3.63M Buy
28,936
+10,612
+58% +$1.35M 0.81% 56
2025
Q3
$2.45M Buy
18,324
+3,614
+25% +$474K 0.63% 66
2025
Q2
$2M Buy
+14,710
New +$1.94M 0.63% 67
2024
Q1
Sell
-1,966
Closed -$216K 121
2023
Q4
$216K Buy
+1,966
New +$196K 0.12% 141
2022
Q1
Sell
-1,764
Closed -$248K 98
2021
Q4
$248K Sell
1,764
-2,850
-62% -$365K 0.16% 90
2021
Q3
$545K Buy
4,614
+156
+3% +$19.2K 0.4% 62
2021
Q2
$517K Buy
4,458
+1,807
+68% +$211K 0.4% 76
2021
Q1
$318K Buy
+2,651
New +$314K 0.3% 84

Other funds holding ABT

Thrive Capital Management (Pennsylvania)'s ABT Position: Q1 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Abbott (ABT) stake by 14% in Q1 2026, buying an estimated $443K and bringing the position to 32,859 shares worth $3.37M. The position accounts for 0.74% of the portfolio, ranked #65.

Thrive Capital Management (Pennsylvania) first reported a position in ABT in Q1 2021 and has held it in 9 quarters since. The position peaked at $3.63M in Q4 2025. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Thrive Capital Management (Pennsylvania) held 32,859 shares of Abbott worth $3.37M as of Q1 2026.
  • Thrive Capital Management (Pennsylvania) bought 3,923 Abbott shares in Q1 2026, an estimated $443K.
  • Abbott made up 0.74% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #65 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Abbott in Q1 2021 and has held it in 9 quarters since.
  • Thrive Capital Management (Pennsylvania)'s Abbott position peaked at $3.63M in Q4 2025.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.